Two countries, more than ten centers
Specialists from China and the US join the board on an ongoing basis and review cases on a shared schedule.
TREATMENT PLAN
The treatment plan matters more than the treatment itself. If the strategy is chosen wrongly, time is lost — and time is the one thing an oncology patient has little of. We bring together specialists from China and the US to review your case and propose an individual plan.
WHY IT MATTERS
A wrong strategy costs the most: it takes away the thing an oncology patient has least of — time. A well-thought-out plan is a “super navigator”: it keeps you from going the wrong way and from spending months on tries and U-turns.
The case is reviewed together, not one specialty at a time
A single specialist’s opinion from one discipline
EXPERT TEAM
More than 100 experts take part in the boards — titles and affiliations are listed on the experts page
Specialists from China and the US join the board on an ongoing basis and review cases on a shared schedule.
Practicing specialists from the group take part in the review — the same people who then carry out the prescribed treatment.
Titles, organizations and areas of work of more than 100 experts from China and the US are collected on the experts page.
INTERNATIONAL STANDARDS
International standards of care, built on evidence-based medicine
Decisions rest on evidence-based principles and standardized practice — that is what makes the plan more precise and more reliable.
We use up-to-date American consensus statements and treatment standards: that lays the foundation for the planned treatment that follows.
Experts from both countries review the case against the same international guidelines.
American specialists communicate freely in Chinese and English, so the international review loses nothing to translation.
HOW THE TEAM WORKS
Five mechanisms that make sure the plan is not just “an opinion” but actually gets implemented
MDT specialists take part on a permanent basis and on a fixed schedule — they are not invited in for a single case.
The team has a dedicated case manager, the treating physician and a verifying physician: personal support at every stage.
The MDT team contacts the patient’s treating physician directly so the plan is carried out to standard. American specialists follow the treatment and adjust it when needed.
If needed, the patient can be treated at the group’s oncology centers — and can also get green-channel access to China’s leading hospitals.
We do not leave the patient with a finished document: specialists follow the plan’s execution to the end, so the decision actually reaches treatment.
HOW THE REVIEW WORKS
What takes place in a review — and what you walk away with
The review runs on a fixed schedule. Nobody is gathered for a single case — the team is a standing one.
Radiation oncology, drug therapy, surgery, medical physics, imaging, pathology, rehabilitation, nutrition and nursing care.
Target contouring, treatment regimen, field placement, dose distribution and dose limits for surrounding organs — based on the specific case.
A refined diagnosis and stage, a comprehensive treatment plan, the sequence and scope of interventions, and quality-control criteria.
REGULAR BOARDS
Nine standing directions, organized by discipline; whether a given condition fits the board is judged by physicians from the records — the list of treatable conditions is on the treatment page
ABOUT THE BOARD
The seven things patients ask most often about the China–US MDT
A multidisciplinary team: pathology, radiology, surgery, medical oncology, radiation oncology, nutritional support and rehabilitation. Specialists from both countries build an individual plan together — from refining the diagnosis to long-term follow-up.
The case is reviewed by a multidisciplinary team from centers in China and the US against unified international guidelines — instead of the opinion of a single specialist from one field.
No. MDT specialists take part on a permanent basis and on a fixed schedule — this is a standing team, not a one-time gathering.
The initial assessment comes within 24 hours. Requests received before 12:00 are reviewed the same day where possible; those received after 12:00 — by noon the next day.
The initial assessment is free. The consultation itself is a paid service.
An individual treatment plan and a written report. American specialists support the implementation of the plan and adjust it when necessary.
Yes. If needed, the patient can be treated at the group’s oncology centers; we can also help arrange green-channel access to China’s leading hospitals.
Share the records first; Chinese and US experts will outline the treatment direction
WhatsApp:+996 880 470 606